World's Best Scientists 2026 revealed!
Alessandro Gronchi

Alessandro Gronchi

D-Index & Metrics

Medicine

D-Index
112
Citations
42953
World Ranking
5172
National Ranking
162

Alessandro Gronchi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alessandro Gronchi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 575 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alessandro Gronchi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alessandro Gronchi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 112 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alessandro Gronchi is affiliated with the University of Milan in Italy and has contributed extensively to the field of medicine, particularly in oncology and surgical treatment approaches. Their research focuses heavily on sarcoma diagnosis and treatment, a specialized subset of oncology addressing both soft tissue and visceral tumors.

The primary fields of study for this scientist include Medicine, with a particular concentration in Pulmonary and Respiratory Medicine, Oncology, Rheumatology, Cardiology and Cardiovascular Medicine, and Surgery. This broad spectrum reflects multidisciplinary engagement relevant to cancer and tumor research as well as clinical management of related diseases.

Frequent topics explored by Gronchi comprise:

  • Sarcoma Diagnosis and Treatment
  • Vascular Tumors and Angiosarcomas
  • Cardiac Tumors and Thrombi
  • Bone Tumor Diagnosis and Treatments
  • Soft Tissue Tumor Case Studies
  • Neurofibromatosis and Schwannoma Cases
  • Gastrointestinal Tumor Research and Treatment

Collaboration is a significant aspect of Alessandro Gronchi's research, with frequent co-authors including Silvia Stacchiotti, Marco Fiore, Dario Callegaro, Paolo G. Casali, and Sandro Pasquali, which illustrates an active participation in joint studies and clinical guideline developments.

Their publication record is substantial, with numerous articles appearing in leading medical and oncology journals. Frequent venues for publication include:

  • Annals of Surgical Oncology
  • Journal of Clinical Oncology
  • European Journal of Surgical Oncology
  • European Journal of Cancer
  • Cancer

Significant recent publications authored by Alessandro Gronchi include:

  • Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up (2021) in Annals of Oncology
  • Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine (2020) in CA A Cancer Journal for Clinicians (co-authored)
  • Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up (2021) in Annals of Oncology (co-authored)
  • The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients (2020) in European Journal of Cancer (co-authored)
  • Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial (2020) in The Lancet Oncology (co-authored)

This profile presents a scientific career characterized by a focus on clinical guidelines and treatment approaches for sarcomas and related tumors, reflecting active involvement in both research and clinical practice communities.

Best Publications

  • Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

    George D. Demetri;Robert S. Benjamin;Charles D. Blanke;Jean Yves Blay

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

    Jean Yves Blay;Sylvie Bonvalot;Paolo Casali;Haesun Choi

  • Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group

    Alessandro Gronchi;Dirk C. Strauss;Rosalba Miceli;Sylvie Bonvalot

  • Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Paolo G. Casali;Jean-Yves Blay;Alexia Bertuzzi;Stefan Bielack

  • Aggressive Surgical Policies in a Retrospectively Reviewed Single-Institution Case Series of Retroperitoneal Soft Tissue Sarcoma Patients

    Alessandro Gronchi;Salvatore Lo Vullo;Marco Fiore;Chiara Mussi

  • Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

    Federica Grosso;Robin L. Jones;George D. Demetri;Ian R. Judson

  • Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P.G. Casali;S. Bielack;N. Abecassis;H.T. Aro

  • Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

    Alessandro Gronchi;Stefano Ferrari;Vittorio Quagliuolo;Javier Martin Broto

  • Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.

    Andrea Ferrari;Palma Dileo;Michela Casanova;Rossella Bertulli

  • Malignant peripheral nerve sheath tumors: Prognostic factors and survival in a series of patients treated at a single institution

    Matteo Anghileri;Rosalba Miceli;Marco Fiore;Luigi Mariani

  • Quality of Surgery and Outcome in Extra-Abdominal Aggressive Fibromatosis: A Series of Patients Surgically Treated at a Single Institution

    Alessandro Gronchi;P. G. Casali;L. Mariani;S. Lo Vullo

  • Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis

    Dario Callegaro;Rosalba Miceli;Sylvie Bonvalot;Peter Ferguson

  • A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient.

    Elena Tamborini;Lorena Bonadiman;Angela Greco;Veronica Albertini

  • Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment

    Marco Fiore;Françoise Rimareix;Luigi Mariani;Julien Domont

  • Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.

    Adriana C. Gamboa;Alessandro Gronchi;Kenneth Cardona

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO (vol 16, pg 566, 2005)

    JY Blay;S Bonvalot;P Casali;H Choi

  • Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P.G. Casali;S. Bielack;N. Abecassis;H.T. Aro

  • Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

Frequent Co-Authors

Paolo G. Casali
Paolo G. Casali University of Milan
Silvia Stacchiotti
Silvia Stacchiotti University of Milan
Silvana Pilotti
Silvana Pilotti University of Milan
Marco Fiore
Marco Fiore IMDEA Networks
Angelo Paolo Dei Tos
Angelo Paolo Dei Tos University of Padua
Peter Hohenberger
Peter Hohenberger Heidelberg University
Chandrajit P. Raut
Chandrajit P. Raut Brigham and Women's Hospital
Piotr Rutkowski
Piotr Rutkowski Maria Sklodowska-Curie National Research Institute of Oncology
Jean-Yves Blay
Jean-Yves Blay Claude Bernard University Lyon 1
Hans Gelderblom
Hans Gelderblom Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to many related degrees and career options—several of which can be accessed online. For those interested in mental health care, pmhnp online programs offer a streamlined path to becoming a psychiatric nurse practitioner, providing advanced, specialized training via flexible online formats.

For students motivated by the organizational side of healthcare, a bachelors in healthcare administration is an accessible way to start a leadership journey. Options also exist for those wishing to further their expertise—pursue the cheapest mha online programs to gain advanced skills in healthcare management without breaking the bank.

Aspiring to the highest levels of practice? Doctoral candidates can seek out the least expensive dnp programs, combining cost-effectiveness with the flexibility to study while working. Each of these online degree paths can help you move toward rewarding roles in the rapidly growing healthcare sector.

Best Scientists Citing Alessandro Gronchi

Trending Scientists

Recently Published Articles